Study S003387

Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT00306098
Study type: INTERVENTIONAL
Phase: PHASE2
Masking: NONE
Status: COMPLETED
Enrollment: 26
Start: 2000-12
Primary completion: 2004-07-04
Lead sponsor: Rodolfo Alejandro
Conditions: Diabetes Mellitus, Type I
Interventions: DRUG:islets
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: NIH:1U42RR016603-01; OTHER:HRSA # 1 R38OT01367-01-00; OTHER_GRANT:No Number

Registered primary outcomes

a1c less than 6.5 without severe hypoglycemia [for the duration of islet graft function]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0025342	Long-term metabolic and hormonal effects of exenatide on islet transplant recipients with allograft dysfunction. Faradji RN, Cell transplantation	2009	Randomized trial	PMID 20003758 DOI	cites ClinicalTrials.gov:NCT00306098; registry reference DERIVED:20003758
R0028020	Improved long-term health-related quality of life after islet transplantation. Tharavanij T, Transplantation	2008	Nonrandomized study	PMID 19005394 DOI	cites ClinicalTrials.gov:NCT00306098; registry reference DERIVED:19005394